Curbing the menace of antimicrobial resistance in developing countries

Harm Reduction Journal

Volumn 6, Issue , 2009, Pages

  Nweneka, Chidi V ^a   Tapha Sosseh, Ndey ^b   Sosa, Anibal ^b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b Alliance for the Prudent Use of Antibiotics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CHLOROQUINE; KETOLIDE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASIA; BEHAVIOR; BIOMEDICINE; DEVELOPING COUNTRY; DRUG MISUSE; EPIDEMIC; FRANCE; HEALTH CARE; HEALTH CARE FACILITY; HEALTH EDUCATION; HONG KONG; HUMAN; INFORMATION PROCESSING; MEDICAL INFORMATION; NONHUMAN; NORTH KOREA; NOTE; POLITICS; POVERTY; PUBLIC HEALTH; SOCIAL ASPECT; SOCIOECONOMICS; SOUTH AFRICA; SOUTH KOREA; SPAIN; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

EID: 71049127493     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-6-31     Document Type: Note

References (20)

1. Denys GA, Koch KM, Dowzicky MJ. Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Am J Infect Control 2007, 35(8):521-526. 10.1016/j.ajic.2006.11.004, 17936143.
2. Potz NA, Hope R, Warner M, Johnson AP, Livermore DM. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 2006, 58(2):320-326. 10.1093/jac/dkl217, 16735428.
3. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 2005, 56(3):455-462. 10.1093/jac/dki266, 16046464.
4. de Kraker M, Sande-Bruinsma N. Trends in antimicrobial resistance in Europe: update of EARSS results. Euro Surveill 2007, 12(3):E070315-070313.
5. Sharma R, Sharma CL, Kapoor B. Antibacterial resistance: current problems and possible solutions. Indian J Med Sci 2005, 59(3):120-129. 10.4103/0019-5359.15091, 15805685.
6. Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002, 50(Suppl S1):25-37.
7. Felmingham D, Canton R, Jenkins SG. Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004. J Infect 2007, 55(2):111-118. 10.1016/j.jinf.2007.04.006, 17568680.
8. Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2006, 2:6. 10.1186/1744-8603-2-6, 1502134, 16603071.
9. Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J Infect Dis 2007, 196(Suppl 3):S482-490. 10.1086/521121, 18181698.
10. Finland M. Emergence of antibiotic resistance in hospitals, 1935-1975. Rev Infect Dis 1979, 1(1):4-22.
11. Frank U, Kleissle EM, Daschner FD, Leibovici L, Paul M, Andreassen S, Schonheyder HC, Cauda R, Tacconelli E. Multicentre study of antimicrobial resistance and antibiotic consumption among 6,780 patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 2006, 25(12):815-817. 10.1007/s10096-006-0211-2, 17066301.
12. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997, 337(7):441-446. 10.1056/NEJM199708143370701, 9250845.
13. Priest P, Yudkin P, McNulty C, Mant D. Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study. Bmj 2001, 323(7320):1037-1041. 10.1136/bmj.323.7320.1037, 59384, 11691763.
14. Livermore DM, Stephens P, Weinberg J, Johnson AP, Gifford T, Northcott D, James D, George RC, Speller DC. Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to in relation to antibacterial prescribing. J Antimicrob Chemother 1997, 46(3):411-422.
15. Goossens H, Ferech M, Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365(9459):579-587.
16. Larson E. Community factors in the development of antibiotic resistance. Annu Rev Public Health 2007, 28:435-447. 10.1146/annurev.publhealth.28.021406.144020, 17094768.
17. Antimicrobial resistance. , http://www.who.int/mediacentre/factsheets/fs194/en/print.html
18. Jones RN. The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance. Diagn Microbiol Infect Dis 1996, 25(4):153-161. 10.1016/S0732-8893(96)00099-5, 8937839.
19. Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med 2007, 20(6):533-539. 10.3122/jabfm.2007.06.070019, 17954860.
20. Editorial (ed) Antimicrobial Resistance: a global threat. 2000,